GlassScriptPhysician profile
Melanie Wright Baldwin
NPI 1285474965
$869.05
in general payments reported to CMS, 2019-2025
10 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $588 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $164.09 | 2024 | Caplyta |
| Amgen INC. | $145.14 | 2024 | Evenity, Prolia |
| Tg Therapeutics, INC. | $125.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $112.47 | 2024-2025 | Tezspire, Breztri |
| Merck Sharp & Dohme LLC | $75.39 | 2024-2025 | Verquvo |
| Abbvie INC. | $69.44 | 2024-2025 | |
| Lundbeck LLC | $65.84 | 2024 | Rexulti |
| Alkermes, INC. | $55.96 | 2024 | Aristada, Lybalvi, Vivitrol |
| Supernus Pharmaceuticals, INC. | $32.84 | 2024 | Qelbree |
| Pharming Healthcare, INC. | $22.88 | 2025 | Ruconest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.